Argenica Therapeutics Ltd Total Liabilities

Latest as of December 2025: AU$1.76 Million AUD ≈ $1.24 Million USD

Argenica Therapeutics Ltd total liabilities. Based on the latest financial reports, Argenica Therapeutics Ltd (AGN) has total liabilities worth AU$1.76 Million AUD (≈ $1.24 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check AGN asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Argenica Therapeutics Ltd (2019–2024)

Total liabilities of Argenica Therapeutics Ltd from 2019 to 2024. This chart illustrates how Argenica Therapeutics Ltd's total liabilities have evolved over time, based on quarterly financial data.

Argenica Therapeutics Ltd Competitors by Total Liabilities

The table below lists competitors of Argenica Therapeutics Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Triller Group Inc. NASDAQ:ILLR	USA	$352.12 Million
Savannah Goldfields Ltd AU:SVG	Australia	AU$33.16 Million
PHOENIX NEW MED.ADR 1/48 F:1PX	Germany	€541.47 Million
Lions Bay Capital Inc V:LBI	Canada	CA$3.22 Million
Peregrine Gold Ltd AU:PGD	Australia	AU$539.02K
Turbo Mech Bhd KLSE:5167	Malaysia	RM11.90 Million
PT Cilacap Samudera Fishing Industry Tbk JK:ASHA	Indonesia	Rp32.64 Billion
Zenta Group Company Limited NASDAQ:ZTG	USA	$407.14K

Liability Composition Analysis (2019–2024)

This chart breaks down Argenica Therapeutics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see AGN current and non-current assets.

Liquidity & Leverage Metrics

Argenica Therapeutics Ltd Total Liabilities Ratios Explained

Argenica Therapeutics Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.51	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.34	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Argenica Therapeutics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Argenica Therapeutics Ltd (2019–2024)

The table below shows the annual total liabilities of Argenica Therapeutics Ltd from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$3.80 Million ≈ $2.69 Million	+56.66%
2023-12-31	AU$2.43 Million ≈ $1.72 Million	+29.46%
2022-12-31	AU$1.87 Million ≈ $1.33 Million	+154.71%
2021-12-31	AU$735.91K ≈ $520.70K	+72.86%
2020-12-31	AU$425.72K ≈ $301.22K	+18.50%
2019-12-31	AU$359.26K ≈ $254.20K	--

About Argenica Therapeutics Ltd

AU:AGN Australia Biotechnology

Market Cap

$9.09 Million

AU$12.85 Million AUD

Market Cap Rank

#27176 Global

#1283 in Australia

Share Price

AU$0.10

Change (1 day)

-13.04%

52-Week Range

AU$0.09 - AU$0.34

All Time High

AU$0.99